BRUGIA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.576
EU - Europa 2.028
AS - Asia 1.577
SA - Sud America 125
AF - Africa 43
OC - Oceania 18
Totale 6.367
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.527
RU - Federazione Russa 686
IT - Italia 544
CN - Cina 457
SG - Singapore 444
PL - Polonia 230
HK - Hong Kong 223
IE - Irlanda 121
VN - Vietnam 113
KR - Corea 111
BR - Brasile 99
DE - Germania 86
SE - Svezia 83
FR - Francia 70
FI - Finlandia 62
IN - India 52
JO - Giordania 44
AT - Austria 39
BD - Bangladesh 37
CA - Canada 29
GB - Regno Unito 25
ID - Indonesia 25
JP - Giappone 22
NL - Olanda 20
AU - Australia 17
CH - Svizzera 17
MX - Messico 15
ZA - Sudafrica 15
ES - Italia 14
IQ - Iraq 10
PK - Pakistan 10
UA - Ucraina 9
AR - Argentina 8
TR - Turchia 8
UZ - Uzbekistan 7
NG - Nigeria 6
PH - Filippine 6
BE - Belgio 5
CL - Cile 4
DZ - Algeria 4
EC - Ecuador 4
MA - Marocco 4
PE - Perù 4
BJ - Benin 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
EG - Egitto 3
NO - Norvegia 3
VE - Venezuela 3
AL - Albania 2
GR - Grecia 2
GT - Guatemala 2
KE - Kenya 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
UY - Uruguay 1
Totale 6.367
Salva come PNG Salva come JPEG
Città #
Santa Clara 588
Ashburn 448
Singapore 310
Warsaw 225
Hong Kong 189
San Jose 138
Chandler 123
Dublin 121
Hefei 113
Seoul 111
Fairfield 100
Florence 99
Milan 87
Beijing 83
Dallas 54
Seattle 52
Houston 50
Cambridge 49
The Dalles 49
Los Angeles 48
Woodbridge 45
Buffalo 43
Munich 43
Vienna 37
Wilmington 37
New York 36
Hanoi 33
Helsinki 33
Moscow 33
Altamura 32
Council Bluffs 31
Ho Chi Minh City 31
Paris 31
Lauterbourg 29
Lawrence 28
Rome 28
Shanghai 26
Ann Arbor 25
Tokyo 22
Boston 21
Jakarta 21
Mumbai 21
Bremen 20
Princeton 20
Turku 19
Kent 18
Bern 17
Melbourne 16
Boardman 15
São Paulo 13
Bologna 12
Medford 12
Orem 12
Pune 12
Clifton 11
Johannesburg 10
Naples 10
Frankfurt am Main 9
Toronto 9
Barcelona 8
Bengaluru 8
Brescia 8
Dong Ket 8
Lappeenranta 8
London 7
Tashkent 7
Atlanta 6
Montreal 6
Phoenix 6
Turin 6
Vancouver 6
Brooklyn 5
Brussels 5
Charlotte 5
Chennai 5
Denver 5
Falls Church 5
Guangzhou 5
Mexico City 5
Shenzhen 5
Stockholm 5
Venice 5
Abuja 4
Amandola 4
Ancona 4
Bari 4
Can Tho 4
Cinisello Balsamo 4
Da Nang 4
Genoa 4
Haiphong 4
Hangzhou 4
Hải Dương 4
Miano 4
Nuremberg 4
San Diego 4
Yubileyny 4
Abidjan 3
Alba 3
Amman 3
Totale 4.166
Salva come PNG Salva come JPEG
Nome #
Emerging drugs in refractory colorectal cancer 327
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 286
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 247
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 239
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 236
Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer. 231
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 231
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 227
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 224
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 206
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 203
Current status and future perspectives in HER2 positive advanced gastric cancer 201
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 201
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 196
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 193
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 190
Physical exercise and eating habits in cancer survivors 189
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 187
Somatostatin analogs in pregnant patients with neuroendocrine tumor 186
Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy 183
In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations" 182
Results of the observational prospective RealFLOT study 180
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 180
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 178
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 177
Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma 171
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 165
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 162
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO 157
Regorafenib also can cause osteonecrosis of the jaw 155
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 135
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 92
Beneath the surface of colorectal cancer: Unmasking the evolving nature of (Neo)RAS 43
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT) 40
Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift 40
Totale 6.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.766
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 4 7 5 3 2 10 1 20 11 13 16 46
2022/2023651 32 110 18 60 45 121 70 55 80 9 20 31
2023/2024398 9 25 37 18 20 62 25 81 8 34 34 45
2024/20251.991 63 175 111 330 503 265 30 123 106 74 92 119
2025/20262.530 329 304 245 215 301 94 293 112 136 177 75 249
2026/20271 1 0 0 0 0 0 0 0 0 0 0 0
Totale 6.440